Cytochrome-P450 2B1 gene silencing attenuates puromycin aminonucleoside-induced cytotoxicity in glomerular epithelial cells

Kidney International

Volumn 78, Issue 2, 2010, Pages 182-190

  Tian, Niu ^a   Arany, Istvan ^a   Waxman, David J ^b   Baliga, Radhakrishna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

Author keywords

cytochrome P450; cytotoxicity; gene expression oxidative stress

Indexed keywords

CASPASE 3; CYTOCHROME P450 2B1; ENZYME PRECURSOR; EPITHELIAL CELL ADHESION MOLECULE; HEME OXYGENASE 1; MESSENGER RNA; PROCASPASE 12; PUROMYCIN AMINONUCLEOSIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE OVEREXPRESSION; GENE SILENCING; GLOMERULUS EPITHELIUM; HISTOPATHOLOGY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; RAT; TRANSCRIPTION TERMINATION;

EID: 77954242629     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.100     Document Type: Article

References (64)

1. Ueda N, Baliga R, Shah SV. Role of catalytic iron in an animal model of minimal change nephrotic syndrome. Kidney Int 1996; 49: 370-373.
2. Gonick H (ed). Current Nephrology. Mosby Year Book: Chicago, 1997.
3. Nelson DR, Koymans L, Kamataki T et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1-42.
4. Kuthan H, Tsuji H, Graf H et al. Generation of superoxide anion as a source of hydrogen peroxide in a reconstituted monooxygenase system. FEBS Lett 1978; 91: 343-345.
5. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPHsupported oxidase activity and lipid peroxidation dependent on ethanolinducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989; 38: 1313-1319.
6. Nordblom GD, Coon MJ. Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch Biochem Biophys 1977; 180: 343-347.
7. Hirt DL, Jacobson HR. Functional effects of cytochrome P450 arachidonate metabolites in the kidney. Semin Nephrol 1991; 11: 148-155.
8. Carroll MA, Balazy M, Huang DD et al. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int 1997; 51: 1696-1702.
9. Baliga R, Zhang Z, Baliga M et al. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 1998; 54: 1562-1569.
10. Nakao A, Faleo G, Shimizu H et al. Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int 2008; 74: 1009-1016.
11. Liu L, Bridges RJ, Eyer CL. Effect of cytochrome P450 1A induction on oxidative damage in rat brain. Mol Cell Biochem 2001; 223: 89-94.
12. Isayama F, Froh M, Bradford BU et al. The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice. Free Radic Biol Med 2003; 35: 1568-1581.
13. Dostalek M, Brooks JD, Hardy KD et al. In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Mol Pharmacol 2007; 72: 1419-1424.
14. Liu H, Baliga M, Bigler SA et al. Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells. Nephron Exp Nephrol 2003; 94: e17-e24.
15. Liu H, Bigler SA, Henegar JR et al. Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome. Kidney Int 2002; 62: 868-876.
16. Shankland SJ. The podocytes response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147.
17. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015.
18. Caulfield JP, Reid JJ, Farquhar MG. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 1976; 34: 43-59.
19. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 2000; 36: 181-199.
20. Liu H, Baliga R. Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 2005; 16: 1985-1992.
21. Lachapelle M, Bendayan M. Contractile proteins in podocytes: immunocytochemical localization of actin and alpha-actinin in normal and nephrotic rat kidneys. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 105-111.
22. Hirsch-Ernst KI, Schlaefer K, Bauer D et al. Repression of phenobarbitaldependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures. Mol Pharmacol 2001; 59: 1402-1409.
23. Lee CM, Kim BY, Li L et al. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem 2008; 283: 889-898.
24. Waxman DJ, Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 1992; 281(Pt 3): 577-592.
25. Honkakoski P, Negishi M. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem J 1998; 330(Pt 2): 889-895.
26. Dostalek M, Hardy KD, Milne GL et al. Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. J Biol Chem 2008; 283: 17147-17157.
27. Kawaguchi M, Yamada M, Wada H et al. Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 1992; 72: 329-340.
28. Ricardo SD, Bertram JF, Ryan GB. Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies. Kidney Int 1994; 45: 1057-1069.
29. Imaoka S, Osada M, Minamiyama Y et al. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 2004; 203: 117-125.
30. Tong V, Chang TK, Chen J et al. The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats. Free Radic Biol Med 2003; 34: 1435-1446.
31. Baliga R, Zhang Z, Baliga M et al. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 1996; 49: 362-369.
32. Bysani GK, Kennedy TP, Ky N et al. Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 1990; 86: 1434-1441.
33. Paller MS, Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 1994; 91: 7002-7006.
34. Liu H, Shah SV, Baliga R. Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am J Physiol Renal Physiol 2001; 280: F88-F94.
35. Karuzina II, Archakov AI. Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions. Free Radic Biol Med 1994; 17: 557-567.
36. Bissell DM, Hammaker LE. Cytochrome P-450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys 1976; 176: 91-102.
37. Howley B, Fearnhead HO. Caspases as therapeutic targets. J Cell Mol Med 2008; 12: 1502-1516.
38. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003; 22: 8543-8567.
39. Kanjanabuch T, Ma LJ, Chen J et al. PPAR-gamma agonist protects podocytes from injury. Kidney Int 2007; 71: 1232-1239.
40. Yoneda T, Imaizumi K, Oono K et al. Activation of caspase-12, anendoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 2001; 276: 13935-13940.
41. Rao RV, Peel A, Logvinova A et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002; 514: 122-128.
42. Morishima N, Nakanishi K, Takenouchi H et al. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002; 277: 34287-34294.
43. Eto N, Wada T, Inagi R et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int 2007; 72: 455-463.
44. Ransom RF, Lam NG, Hallett MA et al. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005; 68: 2473-2483.
45. Koshikawa M, Mukoyama M, Mori K et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 2005; 16: 2690-2701.
46. Shibata S, Nagase M, Fujita T. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol 2006; 17: 754-764.
47. Brosius III FC, Alpers CE, Bottinger EP et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512.
48. Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol 2003; 23: 161-171.
49. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 2009; 296: F213-F229.
50. Cheng ZZ, Patari A, Aalto-Setala K et al. Hypercholesterolemia is a prerequisite for puromycin inducible damage in mouse kidney. Kidney Int 2003; 63: 107-112.
51. Zheng Z, Pavlidis P, Chua S et al. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Am Soc Nephrol 2006; 17: 1796-1800.
52. Chen A, Wei CH, Sheu LF et al. Induction of proteinuria by adriamycin or bovine serum albumin in the mouse. Nephron 1995; 69: 293-300.
53. Jo YI, Cheng H, Wang S et al. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Nephron Exp Nephrol 2007; 107: e87-e94.
54. Michaelis UR, Falck JR, Schmidt R et al. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 321-326.
55. Li CC, Lii CK, Liu KL et al. n-6 and n-3 polyunsaturated fatty acids downregulate cytochrome P-450 2B1 gene expression induced by Phenobarbital in primary rat hepatocytes. J Nutr Biochem 2006; 17: 707-715.
56. Bogaards JJ, Bertrand M, Jackson P et al. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000; 30: 1131-1152.
57. Lemasters JJ, Nieminen AL, Qian T et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998; 1366: 177-196. (Pubitemid 28467031)
58. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
59. Tzanakakis ES, Waxman DJ, Hansen LK et al. Long-term enhancement of cytochrome P450 2B1/2 expression in rat hepatocyte spheroids through adenovirus-mediated gene transfer. Cell Biol Toxicol 2002; 18: 13-27.
60. Rosenkranz AR, Schmaldienst S, Stuhlmeier KM et al. A microplate assay for the detection of oxidative products using 20,70-ichlorofluoresceindiacetate. J Immunol Methods 1992; 156: 39-45.
61. Baliga R, Zhang Z, Shah SV. Role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells. Kidney Int 1996; 50: 1118-1124.
62. Quigg RJ, Cybulsky AV, Jacobs JB et al. Anti-Fx1A produces complementdependent cytotoxicity of glomerular epithelial cells. Kidney Int 1988; 34:43-52.
63. Bradd SJ, Dunn MJ. Analysis of membrane proteins by western blotting and enhanced chemiluminescence. Methods Mol Biol 1993; 19: 211-218.
64. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.